Our pipeline
is a commitment
to patients with
rare or unmet
medical conditions


Delta4 is a (bio)-tech company
discovering new drugs with
a known safety profile, using
the sophisticated knowledge platform, Hyper-C.

Hyper-C a humongous conglomerate of highly specific algorithms – supported by AI – which finds so far undetected relationships between drugs and disease areas, enables us to detect relationships with unprecedented speed.

Our team of highly skilled computational biologists utilize Hyper-C.

As a result, new therapy options find their way to the patient faster, and more efficient.